ResearcherFlinders UniversityActive in the last 2 years
Amitesh Chandra Roy
Matched on ORCID iD 0000-0002-3583-7981; OpenAlex author ID A5082298944. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- Predicting recurrence patterns and outcomes following resection of pancreatic ductal adenocarcinoma: a contemporary real-world data cohort study. Co-author DOI 10.1097/ms9.0000000000004919↗
- Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited int… Last author DOI 10.1080/14737140.2022.2002689↗
- Phase I Trial of nab-Paclitaxel Administered Concurrently With Radiotherapy in Patients With Locally Advanced Inoperable Pancreatic Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002065↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Timothy Jay Price · 2 shared papers, 2022 · strength 0.26
- Paper Phase I Trial of nab-Paclitaxel Administered Concurrently With Radiotherapy in Patients With Locally Advanced Inoperabl… DOI 10.1097/mpa.0000000000002065↗
- Paper Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestin… DOI 10.1080/14737140.2022.2002689↗
- Christos Stelios Karapetis · 2 shared papers, 2022 · strength 0.26
- Paper Phase I Trial of nab-Paclitaxel Administered Concurrently With Radiotherapy in Patients With Locally Advanced Inoperabl… DOI 10.1097/mpa.0000000000002065↗
- Paper Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestin… DOI 10.1080/14737140.2022.2002689↗
- Benjamin P. T. Loveday · 1 shared paper, 2026 · strength 0.24
- Matthew Burge · 1 shared paper, 2026 · strength 0.24
- Eden Mane · 1 shared paper, 2026 · strength 0.24
- Mehrdad Nikfarjam · 1 shared paper, 2026 · strength 0.24
- Belinda Lee · 1 shared paper, 2026 · strength 0.24
- David Wai-Meng Tai · 1 shared paper, 2026 · strength 0.24
- Nimit Singhal · 1 shared paper, 2022 · strength 0.14
- David Goldstein · 1 shared paper, 2022 · strength 0.13
- Florian Lordick · 1 shared paper, 2022 · strength 0.13
- Nick Pavlakis · 1 shared paper, 2022 · strength 0.13
- Eva Segelov · 1 shared paper, 2022 · strength 0.13
- Lorraine A. Chantrill · 1 shared paper, 2022 · strength 0.13
- Trevor Leong · 1 shared paper, 2022 · strength 0.13
- Adnan M. Nagrial · 1 shared paper, 2022 · strength 0.13
- Ian Chau · 1 shared paper, 2022 · strength 0.13
- Niall Christopher Tebbutt · 1 shared paper, 2022 · strength 0.13
- Mike Nguyen · 1 shared paper, 2022 · strength 0.13
- Daniel John Renouf · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.